Anand Ashwin Patel MD (He/Him)
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor, Director of Inpatient Leukemia Service
Join to View Full Profile
5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Patel an expert in the treatment of myeloproliferative diseases, myelodysplastic syndromes, and leukemias. He is an active researcher whose work is focused on the development of clinical trials to investigate novel therapies that may improve the standard of care for patients with myeloid cancers and leukemia. Dr. Patel has published his research in several well-respected peer-reviewed journals including Blood, Blood Advances, British Journal of Haematology, Cancer, JCI Insight, and Bone Marrow Transplantation.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2018 - 2021
McGaw Medical Center of Northwestern UniversityChief Residency, Internal Medicine, 2017 - 2018- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2014 - 2017
University of Missouri-Columbia School of MedicineClass of 2014
Certifications & Licensure
IL State Medical License 2014 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Early Career Investigator Award National Cancer Institute, 2025
- 40 Under 40 in Cancer Amplity Health, Swim Across America, The National Community Oncology Dispensing Association, Inc. (NCODA), and the Association for Value-Based Cancer Care, 2024
- Medical Alumni Outstanding Young Physician Award University of Missouri School of Medicine, 2024
- Join now to see all
Clinical Trials
- Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) Start of enrollment: 2021 Mar 02
- A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) Start of enrollment: 2022 Aug 05
- A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis Start of enrollment: 2019 Dec 16
- Join now to see all
Publications & Presentations
PubMed
- Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova, Yasmin Abaza, Theodoros Karantanos
Blood Cancer Journal. 2025-08-14 - Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.Orly Leiva, Olivia Liu, Anthony Kanelidis, Stanley Swat, Leo Gozdecki
JACC. Cardiooncology. 2025-08-01 - Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status.Talha Badar, James M Foran, Jan Philipp Bewersdorf, Yu-Hung Wang, Alexander Coltoff
British Journal of Haematology. 2025-08-01
Press Mentions
Back on the Golf Course Rebuilding His Game, Thanks to a Clinical StudySeptember 17th, 2025
UChicago scientists study how the environment is silently shaping your risk for cancerNovember 18th, 2024- Expert Point of View: Anand Ashwin Patel, MDAugust 10th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
